Axsome Therapeutics Inc
NASDAQ:AXSM

Watchlist Manager
Axsome Therapeutics Inc Logo
Axsome Therapeutics Inc
NASDAQ:AXSM
Watchlist
Price: 152.05 USD -1.03% Market Closed
Market Cap: 7.7B USD

Wall Street
Price Targets

AXSM Price Targets Summary
Axsome Therapeutics Inc

Wall Street analysts forecast AXSM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AXSM is 182.31 USD with a low forecast of 149.48 USD and a high forecast of 215.25 USD.

Lowest
Price Target
149.48 USD
2% Downside
Average
Price Target
182.31 USD
20% Upside
Highest
Price Target
215.25 USD
42% Upside
Axsome Therapeutics Inc Competitors:
Price Targets
FAE
Faes Farma SA
3% Upside
TORNTPHARM
Torrent Pharmaceuticals Ltd
7% Upside
ACUTAAS
Acutaas Chemicals Ltd
13% Upside
4530
Hisamitsu Pharmaceutical Co Inc
2% Downside
CLN
Celon Pharma SA
35% Upside
600276
Jiangsu Hengrui Pharmaceuticals Co Ltd
33% Upside
AVDL
Avadel Pharmaceuticals PLC
1% Downside
002603
Shijiazhuang Yiling Pharmaceutical Co Ltd
6% Upside

Revenue
Forecast

Revenue Estimate
Axsome Therapeutics Inc

The compound annual growth rate of Axsome Therapeutics Inc's revenue for the next 4 years is 52%.

N/A
Past Growth
52%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Axsome Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Axsome Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-28%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AXSM's stock price target?
Price Target
182.31 USD

According to Wall Street analysts, the average 1-year price target for AXSM is 182.31 USD with a low forecast of 149.48 USD and a high forecast of 215.25 USD.

What is Axsome Therapeutics Inc's Revenue forecast?
Projected CAGR
52%

The compound annual growth rate of Axsome Therapeutics Inc's revenue for the next 4 years is 52%.

Back to Top